Blog

NEW YORK, NY / ACCESS Newswire / August 25, 2025 / SMX (NASDAQ:SMX) just unveiled a pivotal new milestone in Singapore, announcing a strategic collaboration with Bio-Packaging Pte Ltd-a homegrown leader in PCR, biodegradable, and compostable packaging. This isn’t just another headline. It’s proof that SMX is transforming sustainable packaging into data-rich assets that regulators can trust, brands can defend, and consumers can believe.

The partnership embeds SMX’s invisible molecular marker into Bio-Packaging’s lines at the point of extrusion. From that moment forward, every scan-on the factory floor, in distribution, at point of sale, or at end-of-life-creates a tamper-proof digital twin on SMX’s blockchain. Each bag becomes its own witness, validating recycled content, biodegradability, and compostability in real time. In a world where “green” claims are increasingly challenged, that’s not optional-it’s essential.

As Bio-Packaging’s Director of Business Development Lim Qin Jie put it, customers are demanding proof, not promises. By fusing SMX’s traceability with Bio-Packaging’s PCR, biodegradable and compostable offerings, they can now deliver indisputable evidence that every product lives up to its eco-promise. That’s not marketing-it’s measurable sustainability.

From Innovation to Infrastructure

This deal isn’t happening in isolation. It follows two game-changing announcements earlier this year that set the stage for SMX’s ASEAN surge. Back in April 2025, SMX first joined forces with Aegis Packaging, embedding molecular traceability into its O₂X™ mono-material barrier coating. Already a breakthrough, O₂X™ became more than innovative packaging-it became self-verifying infrastructure. Every unit could now authenticate its own origin, usage, and recovery, no third-party audits required.

Shortly after, SMX announced its collaboration with Skypac Packaging, a regional powerhouse in PP, OPP, HDPE, and LDPE products. Skypac’s ethos-“Paper When Possible, Plastic When Useful”-synced perfectly with SMX’s mission. With molecular markers and blockchain passports integrated, every plastic wrapper or container became fully accountable across its lifecycle. And layered with SMX’s Plastic Cycle Token (PCT), circularity wasn’t just compliance-it was currency.

Put together, these partnerships chart a clear trajectory. SMX isn’t sketching roadmaps or running pilots. It’s embedding itself across materials, technologies, and markets-positioning its platform as the industry’s new benchmark for proof.

Singapore as Launchpad, ASEAN as Inflection Point

Singapore is the ideal launchpad. The nation consumes nearly a million tonnes of plastic annually, with 94% still incinerated. It also sits at the center of ASEAN’s industrial supply chains. By embedding traceability directly into the packaging that circulates daily through supermarkets, retailers, and distributors, SMX and its partners are flipping that equation. Waste becomes certified material. Incineration costs give way to recycling dividends. And sustainability shifts from rhetoric to measurable return.

This momentum also arrives against the backdrop of the recent UN Plastics Treaty negotiations, where more than 150 nations came together to tackle one of the world’s most pressing environmental challenges. While no consensus was reached on issues like production caps versus recycling mandates, the very act of convening showed the seriousness and scale of global commitment. What’s missing is a unifying mechanism-one that can bridge divides and make every position part of the solution, not excluded from it. That’s where SMX steps in as the toolbox every side can use. And benefit from.

Its platform, built on molecular traceability, material efficiency, and blockchain-backed verification, is the ultimate circularity toolbox-able to validate recycled content, authenticate biodegradability, and align with any policy framework. In short, SMX turns ambition into proof.

And ASEAN is where that toolbox is already at work. Singapore and its regional peers are showing how fast policy can translate into practice. From Extended Producer Responsibility schemes to advanced recycling infrastructure, the region is proving that circularity doesn’t have to wait for global consensus. By embedding itself into these supply chains, SMX is helping ASEAN lead the world-turning the challenge of plastics into a model of measurable, inclusive, and profitable sustainability.

A Go-To Global Blueprint

Momentum is the real story. In just a few months, SMX has secured three strategic partnerships across Singapore that span substrates from flexible plastics to barrier coatings to biodegradable films. Each one points to the same conclusion: the future of packaging-and by extension, global manufacturing-belongs to platforms that can prove, price, and profit from sustainability.

And that’s where SMX’s Global Plastics Passport and Plastic Cycle Token come into play. By tying molecular-level data to block-chain records and tokenized value, SMX is turning packaging into a financial instrument-where recycled content and biodegradability aren’t claims, but assets. It’s a system designed not only for Singapore or ASEAN, but for Europe, the U.S., and anywhere regulators, investors, and consumers demand proof over pledges.

SMX isn’t chasing momentum. It’s creating it. And as its footprint in ASEAN deepens, one thing is clear: This isn’t just packaging evolution-it’s the foundation of a global standard

About SMX

As global businesses face new and complex challenges relating to carbon neutrality and meeting new governmental and regional regulations and standards, SMX is able to offer players along the value chain access to its marking, tracking, measuring and digital platform technology to transition more successfully to a low-carbon economy.

About Bio-Packaging

Founded in 2007 and headquartered at Woodlands Spectrum 1, Bio-Packaging Pte Ltd provides HDPE, PCR, biodegradable and certified-compostable carrier bags, produce rolls and industrial liners to supermarkets, food service, retail and industrial clients. The company is ISO 14001-certified and focuses on delivering high-quality, competitively priced, innovative and sustainable packaging solutions.

Forward-Looking Statements

The information in this press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “will,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: successful launch and implementation of SMX’s joint projects with manufacturers and other supply chain participants of steel, rubber, plastic and other materials; changes in SMX’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; SMX’s ability to develop and launch new products and services, including its planned Plastic Cycle Token; SMX’s ability to successfully and efficiently integrate future expansion plans and opportunities; SMX’s ability to grow its business in a cost-effective manner; SMX’s product development timeline and estimated research and development costs; the implementation, market acceptance and success of SMX’s business model; developments and projections relating to SMX’s competitors and industry; and SMX’s approach and goals with respect to technology. These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company’s shares on Nasdaq; changes in applicable laws or regulations; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which SMX operates; the risk that SMX and its current and future collaborators are unable to successfully develop and commercialize SMX’s products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that SMX is unable to secure or protect its intellectual property; the possibility that SMX may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in SMX’s filings from time to time with the Securities and Exchange Commission.

EMAIL: info@securitymattersltd.com

SOURCE: SMX (Security Matters) Public Limited

View the original press release on ACCESS Newswire

MIAMI BEACH, FL / ACCESS Newswire / August 25, 2025 / The Tripathi Foundation Inc. has released a draft manuscript introducing the Equation of Forces (EoF), a proposed unified law of nature that seeks to bring together gravity, electromagnetism, the strong and weak nuclear interactions, and quantum corrections within a single covariant framework.

The work, developed by Dr. GNR Tripathi and Pradeep Tripathi builds systematically from the history of unification – from Newton and Maxwell through Einstein, quantum field theory, and string theory – toward a modern synthesis designed to remain consistent across both classical and quantum regimes.

About the Equation of Forces

The EoF framework presents a single master equation with:

Integration of gravitational, gauge, scalar, and effective correction terms.

Structural safeguards enforcing causality, anomaly cancellation, positivity, and duality symmetries.

Reductions to known physical laws in the appropriate limits, while allowing for new, testable corrections.

The framework is not offered as a final theory, but as a carefully constructed draft for discussion and exploration. Its design emphasizes both consistency with established science and openness to empirical testing in gravitational-wave astronomy, cosmology, particle physics, and laboratory-scale precision experiments.

Continuing a Tradition

This work is presented with deep respect for the tradition of unification that has guided physics for centuries. Each step, from Newton’s universal gravitation to Maxwell’s unification of electricity and magnetism, from Einstein’s general relativity to the Standard Model of particle physics, has demonstrated that nature’s laws grow simpler and more coherent at deeper levels.

The Equation of Forces is offered in that same spirit – as a continuation of this ongoing search for unity, placed before the scientific community with humility and an openness to refinement, testing, and critique.

About the Tripathi Foundation Inc.

The Tripathi Foundation Inc. is dedicated to advancing fundamental inquiry in physics and supporting research that aims to deepen humanity’s understanding of the natural world. [Our apologies for incorrect page numbering.]

SOURCE: Tripathi Foundation Inc

View the original press release on ACCESS Newswire

• Marks a key milestone following the company’s public listing and continued growth as a U.S.-listed SAF company

• Celebrates XCF’s mission to decarbonize the aviation industry through scalable, investor-grade SAF infrastructure

HOUSTON, TEXAS / ACCESS Newswire / August 25, 2025 / XCF Global, Inc. (“XCF”) (Nasdaq:SAFX), a key player in decarbonizing the aviation industry through Sustainable Aviation Fuel (“SAF”), today announces it will ring the Nasdaq Stock Market Opening Bell this morning at Nasdaq’s iconic MarketSite in Times Square. The Opening Bell Ceremony will be broadcast live on the Nasdaq website and social media platforms.

The Opening Bell Ceremony marks a major milestone for XCF following its public listing earlier this year and highlights the company’s momentum in building a global platform of renewable fuel production facilities engineered to accelerate the decarbonization of the aviation industry through the adoption of SAF.

Mihir Dange, Chief Executive Officer and Board Chair of XCF Global commented:

“Becoming a publicly traded company on Nasdaq, one of the largest stock exchanges in the world, is a major milestone for XCF. But today’s ceremony is not just about what we’ve achieved – it’s about where we are going. SAF is fast becoming the defining market of the next decade, and XCF has the early-mover advantage to lead. With our flagship New Rise Reno facility at the core and an ambitious growth plan, we are proud to offer investors access to one of the most dynamic growth stories in renewable fuels. With its focus on growth and innovation, Nasdaq is the perfect home for XCF.”

Join XCF’s Opening Bell Ceremony Online. Today’s Ceremony will be streamed live at: https://www.nasdaq.com/marketsite/bell-ringing-ceremony.

About XCF Global, Inc.

XCF Global, Inc. is a pioneering sustainable aviation fuel company dedicated to accelerating the aviation industry’s transition to net-zero emissions. XCF is developing and operating state-of-the-art clean fuel SAF production facilities engineered to the highest levels of compliance, reliability, and quality. The company is actively building partnerships across the energy and transportation sectors to accelerate the adoption of SAF on a global scale. XCF is listed on the Nasdaq Capital Market and trades under the ticker, SAFX. Current outstanding shares: ~153.2 million; 20% free float (as of August 25, 2025).

To learn more, visit www.xcf.global.

Contacts

XCF Global:
C/O Camarco
XCFGlobal@camarco.co.uk

Media:
Camarco
Andrew Archer | Rosie Driscoll | Violet Wilson
XCFGlobal@camarco.co.uk

Forward Looking Statements

This Press Release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expect”, “intend”, “will”, “estimate”, “anticipate”, “believe”, “predict”, “potential” or “continue”, or the negatives of these terms or variations of them or similar terminology. These forward-looking statements, including, without limitation, statements regarding XCF Global’s expectations with respect to future performance and anticipated financial impacts of the recently completed business combination with Focus Impact BH3 Acquisition Company (the “Business Combination”), estimates and forecasts of other financial and performance metrics, and projections of market opportunity and market share, are subject to risks and uncertainties, which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by XCF Global and its management, are inherently uncertain and subject to material change. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) changes in domestic and foreign business, market, financial, political, and legal conditions; (2) unexpected increases in XCF Global’s expenses resulting from potential inflationary pressures and rising interest rates, including manufacturing and operating expenses and interest expenses; (3) the occurrence of any event, change or other circumstances that could give rise to the termination of negotiations and any agreements with regard to XCF Global’s offtake arrangements; (4) the outcome of any legal proceedings that may be instituted against the parties to the Business Combination or others; (5) XCF Global’s ability to meet Nasdaq’s continued listing standards; (6) XCF Global’s ability to integrate the operations of New Rise and implement its business plan on its anticipated timeline; (7) XCF Global’s ability to raise financing in the future and the terms of any such financing; (8) the New Rise Reno production facility’s ability to produce the anticipated quantities of SAF without interruption or material changes to the SAF production process; (9) XCF Global’s ability to resolve current disputes between its New Rise subsidiary and its landlord with respect to the ground lease for the New Rise Reno facility; (10) XCF Global’s ability to resolve current disputes between its New Rise subsidiary and its primary lender with respect to loans outstanding that were used in the development of the New Rise Reno facility; (11) costs related to the Business Combination and the New Rise acquisitions; (12) the risk of disruption to the current plans and operations of XCF Global as a result of the consummation of the Business Combination; (13) XCF Global’s ability to recognize the anticipated benefits of the Business Combination and the New Rise acquisitions, which may be affected by, among other things, competition, the ability of XCF Global to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (14) changes in applicable laws or regulations; (15) risks related to extensive regulation, compliance obligations and rigorous enforcement by federal, state, and non-U.S. governmental authorities; (16) the possibility that XCF Global may be adversely affected by other economic, business, and/or competitive factors; (17) the availability of tax credits and other federal, state or local government support; (18) risks relating to XCF Global’s and New Rise’s key intellectual property rights; (19) the risk that XCF Global’s reporting and compliance obligations as a publicly-traded company divert management resources from business operations; (20) the effects of increased costs associated with operating as a public company; and (21) various factors beyond management’s control, including general economic conditions and other risks, uncertainties and factors set forth in XCF Global’s filings with the Securities and Exchange Commission (“SEC”), including the final proxy statement/prospectus relating to the Business Combination filed with the SEC on February 6, 2025, this Press Release and other filings XCF Global makes with the SEC in the future. If any of the risks actually occur, either alone or in combination with other events or circumstances, or XCF Global’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that XCF Global does not presently know or that it currently believes are not material that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect XCF Global’s expectations, plans or forecasts of future events and views as of the date of this Press Release. These forward-looking statements should not be relied upon as representing XCF Global’s assessments as of any date subsequent to the date of this Press Release. Accordingly, undue reliance should not be placed upon the forward-looking statements. While XCF Global may elect to update these forward-looking statements at some point in the future, XCF Global specifically disclaims any obligation to do so.

SOURCE: XCF Global, Inc.

View the original press release on ACCESS Newswire

Pairing sustainable materials with “physical-to-digital” authentication to validate recycled-content claim and EPR compliance.

NEW YORK, NY AND SINGAPORE / ACCESS Newswire / August 25, 2025 / SMX (Security Matters) PLC (NASDAQ:SMX; SMXWW), the pioneer of molecular “physical-to-digital” fingerprinting for supply-chain transparency, today announced a strategic collaboration with Bio-Packaging Pte Ltd, a Singaporean manufacturer of Polyethylene, Post-consumer recycle (PCR), biodegradable and certified-compostable general packaging. Established in 2007, Bio-Packaging serves supermarkets, food-service operators and retailers with ISO 14001-accredited, competitively priced solutions that combine quality, affordability and sustainable alternatives.

The collaboration embeds SMX’s invisible molecular marker into Bio-Packaging’s PCR, biodegradable and certified-compostable product lines during extrusion. Each scan-whether at production, distribution, point of sale or end-of-life-writes a tamper-proof “digital twin” to SMX’s blockchain platform, giving brand owners and regulators verified proof of origin, material type, recycling loops and composting outcomes in real time.

SMX believes that brands face growing scrutiny over ‘green’ labelling and packaging end-of-life performance. Integrating the SMX marker with Bio-Packaging’s green solutions can potentially turn every bag into a data-rich asset that proves its sustainability journey.

Lim Qin Jie, Director of Business Development of Bio-Packaging, added: “Our customers trust us for practical, cost-effective packaging that meets Singapore’s high environmental standards. By fusing SMX’s traceability technology with our PCR, biodegradable and compostable offerings, we can now deliver indisputable evidence that each product lives up to its eco-promise.”

Key Features of the Collaboration

• Drop-in marking – SMX’s marker is added during films or bags production without altering the material’s performance.

• Regulatory readiness – Data aligns with Singapore’s forthcoming Extended Producer Responsibility (EPR) scheme for packaging and designed to support global plastic-tax reporting.

• Anti-greenwashing assurance – Embedded metadata to substantiate biodegradability and recycled-content claims, expecting to bolster consumer trust.

Looking Ahead

By empowering local converters with verifiable data, SMX and Bio-Packaging aim to accelerate Singapore’s transition to a zero-waste, high-value circular economy. SMX and Bio-Packaging will work with government agencies and industry groups to scale the platform across additional substrates and end-use sectors, with the goal to make transparent, accountable packaging the new norm across Asia-Pacific and then globally.

For further information contact:

SMX GENERAL ENQUIRIES
E: info@securitymattersltd.com

Follow us through our social channel
@secmattersltd
@smx.tech

About SMX

As global businesses face new and complex challenges relating to carbon neutrality and meeting new governmental and regional regulations and standards, SMX is able to offer players along the value chain access to its marking, tracking, measuring and digital platform technology to transition more successfully to a low-carbon economy.

About Bio-Packaging

Founded in 2007 and headquartered at Woodlands Spectrum 1, Bio-Packaging Pte Ltd provides HDPE, PCR, biodegradable and certified-compostable carrier bags, produce rolls and industrial liners to supermarkets, food service, retail and industrial clients. The company is ISO 14001-certified and focuses on delivering high-quality, competitively priced, innovative and sustainable packaging solutions.

Forward-Looking Statements

The information in this press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “will,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: successful launch and implementation of SMX’s joint projects with manufacturers and other supply chain participants of steel, rubber, plastic and other materials; changes in SMX’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; SMX’s ability to develop and launch new products and services, including its planned Plastic Cycle Token; SMX’s ability to successfully and efficiently integrate future expansion plans and opportunities; SMX’s ability to grow its business in a cost-effective manner; SMX’s product development timeline and estimated research and development costs; the implementation, market acceptance and success of SMX’s business model; developments and projections relating to SMX’s competitors and industry; and SMX’s approach and goals with respect to technology. These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company’s shares on Nasdaq; changes in applicable laws or regulations; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which SMX operates; the risk that SMX and its current and future collaborators are unable to successfully develop and commercialize SMX’s products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that SMX is unable to secure or protect its intellectual property; the possibility that SMX may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in SMX’s filings from time to time with the Securities and Exchange Commission.

SOURCE: SMX (Security Matters)

View the original press release on ACCESS Newswire

CEO Dan O’Toole wants to pay and get paid in Bitcoin

INDIANAPOLIS, INDIANA / ACCESS Newswire / August 25, 2025 / Arrive AI (NASDAQ:ARAI), an autonomous delivery network anchored by patented AI-powered Arrive Points™, is preparing to use Bitcoin cryptocurrency to pay its vendors, clients and employees who prefer it over traditional dollars.

“We think cryptocurrency is a better way to pay, and as we continue to expand our footprint globally, we think our associates will be happy to have this option,” said Arrive AI CEO Dan O’Toole, who will be the first staffer to accept his compensation in cryptocurrency.

O’Toole said he is following the cryptocurrency strategy model established by Micro Strategies.

“Longer term, we see the opportunity to go beyond Bitcoin by creating our own token, an Arrive Coin. It would be designed for use across our entire ecosystem: paying employees and contractors, rewarding loyal customers, settling vendor contracts, and even streamlining transactions within our delivery network. Because our business sits at the intersection of logistics and AI, a proprietary digital currency could enhance transparency, speed and efficiency while giving investors and users a stake in the growth of our platform.”

Additional uses for cryptocurrency the company will consider include keeping cash holdings in Bitcoin and instituting a Bitcoin-denominated At the Market (ATM) program to facilitate fundraising.

A 2024 Deloitte survey showed that more than 6,000 U.S. businesses accept bitcoin as a means of payment. An accompanying Deloitte perspective said crypto offers benefits that traditional currency doesn’t, including real-time and accurate revenue-sharing and enhanced transparency to facilitate back-office reconciliation.

Bitwage, an international payroll services provider, says savvy tech workers prefer cryptocurrency because of its real-time payments across international borders, elimination of some transaction fees and the potential for added value from bitcoin marketplace value, among other considerations. Bitwage said crypto particularly appeals to blockchain developers, remote tech workers and Web3 professionals. The organization cited a 2023 Deloitte report that found more than 60 percent of Millennials and Gen Z view crypto as a key part of the future financial system.

“We’re a tech company on the rise, and we need the absolute best minds in the AI space to help us continue to refine our platform and take advantage of AI-driven learnings as we go,” O’Toole said. “Offering compensation in cryptocurrency – and potentially our own Arrive Coin in the future – is another way to attract and retain those people.”

Arrive AI is in the process of tripling its staff to add artificial intelligence scientists, delivering on the company’s commitment to be AI first in its operation and deliverables. Other jobs will include software and product engineering, underscoring Arrive AI’s commitment to continuous refinements of its proprietary technology and patented products. Additional positions will support critical sales and marketing functions as the company prepares for widespread deployment.

A Q2 2025 North American CFO Signals survey, which polled 200 North American finance chiefs working at companies with at least $1 billion in revenues, showed that 99 percent of responding CFOs said they envisioned using cryptocurrency for business functions in the long term. Nearly a quarter of them said their companies will use crypto for either investments or payments within the next two years. Cited benefits included enhanced protection of customer privacy, improved cross-border transaction facilitation, attracting new customers, faster transactions, elimination of chargebacks, lower processing fees and greater payment volumes.

O’Toole said he also plans on using cryptocurrency as an investment opportunity for company cash on hand.

“Embracing the emergence of Bitcoin allows us to have an upside in balance sheet ‘cash’ which could be a great synergy in our economics,” he said.

-30-

About Arrive AI

Arrive AI’s patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox, whether by drone, ground robot or human courier. The platform provides real-time tracking, smart logistics alerts and advanced chain of custody controls to support shippers, delivery services and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting and security systems to streamline the entire last-mile delivery experience. Learn more at www.arriveai.com. See the company’s press kit here.

Media contact: Cheryl Reed, media@arriveai.com
Investor Relations Contact: Alliance Advisors IR, ARAI.IR@allianceadvisors.com

Cautionary Note Regarding Forward Looking Statements

This news release and statements of Arrive AI’s management in connection with this news release or related events contain or may contain “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements related to future events, which may impact our expected future business and financial performance, and often contain words such as “expects”, “anticipates”, “considers”, “intends”, “plans”, “prepares”, “believes”, “potential”, “will”, “should”, “could”, “would”, “wants”, “optimistic”, “in the process of” or “may” and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management’s current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results, for example, whether the company’s implementation of its crypto strategy could be successful, whether the company will eventually follow through with its plan to use cryptocurrency in its operation, or whether it could be successful in adding ideal workforce, and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Arrive AI’s Registration Statement and other filings with the Securities Exchange Commission, for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.

SOURCE: Arrive AI Inc.

View the original press release on ACCESS Newswire

Breakthrough Therapy designation complements Rusfertide’s Orphan Drug and Fast Track designations, which together confer multiple benefits to the development program

U.S. New Drug Application filing for Rusfertide in polycythemia vera on track for Q4

NEWARK, CA / ACCESS Newswire / August 25, 2025 / Protagonist Therapeutics, Inc. (“Protagonist” or “the Company”) announced today that rusfertide, a potential first-in-class hepcidin-mimetic peptide, has been granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA) for the treatment of erythrocytosis in patients with polycythemia vera (PV). In 2020, rusfertide received Orphan Drug status and Fast Track designation. Breakthrough Therapy Designation is a process designed to expedite the development and review of drugs that are intended to treat a serious condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapies.¹ Breakthrough Therapy Designation also conveys eligibility for priority NDA review¹ and Orphan Drug Designation qualifies sponsors for various incentives including a potential for extended market exclusivity.²

Breakthrough designation for rusfertide was supported by positive 32-week data from the Phase 3 VERIFY study, which was presented as a late breaking abstract highlighting its practice-changing potential during the plenary session at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.

“We are very pleased with the FDA’s decision to grant Breakthrough Therapy Designation to rusfertide, which underscores its potential to demonstrate substantial improvement over available PV therapies,” said Dinesh V. Patel, Ph.D., President and Chief Executive Officer at Protagonist. We remain on track for NDA submission of rusfertide in polycythemia vera by the end of this year.”

“In the VERIFY Phase 3 trial, rusfertide demonstrated positive results across all primary and key secondary endpoints including hematocrit control, decreased phlebotomy dependence, and patient reported outcomes including improvement in fatigue,” said Arturo Molina, M.D., M.S., Chief Medical Officer at Protagonist. “The comprehensive data provide compelling evidence of the potential for rusfertide to address unmet medical needs in patients with PV who are unable to achieve adequate hematocrit control with standard of care or currently available treatments.”

Rusfertide is being co-developed with Takeda Pharmaceuticals pursuant to a worldwide collaboration and license agreement entered in 2024, under which Protagonist remains primarily responsible for development through NDA filing.

About VERIFY
The Phase 3 VERIFY study (NCT05210790) is an ongoing, three-part, global, randomized, placebo-controlled study evaluating rusfertide in 293 patients with polycythemia vera over a 156-week period. The study is evaluating the efficacy and safety of once-weekly, subcutaneously self-administered rusfertide in patients with uncontrolled hematocrit who are phlebotomy dependent despite current standard of care treatment, which could include hydroxyurea, interferon and/or ruxolitinib. The primary endpoint of the study was the proportion of patients achieving a response during weeks 20-32, which was defined as the absence of “phlebotomy eligibility.” To meet phlebotomy eligibility, patients in the study were required to have: confirmed hematocrit ≥45% that was ≥3% higher than their baseline hematocrit value, or hematocrit ≥48%.

All patients have completed their participation in the randomized, placebo-controlled portion of the study evaluating the efficacy and safety of rusfertide plus current treatment versus placebo plus current treatment and are now in the open-label portion of the study.

About Protagonist
Protagonist Therapeutics is a discovery through late-stage development biopharmaceutical company. Two novel peptides derived from Protagonist’s proprietary discovery platform are currently in advanced Phase 3 clinical development, with New Drug Application (NDA) for icotrokinra submitted to the FDA in July and the NDA submission for rusfertide expected by end of 2025. Icotrokinra (formerly, JNJ-2113), a first-in-class investigational targeted oral peptide that selectively blocks the Interleukin-23 receptor (“IL-23R”) is licensed to J&J Innovative Medicines (“JNJ”), formerly Janssen Biotech, Inc.. Following icotrokinra’s joint discovery by Protagonist and JNJ scientists pursuant to the companies’ IL-23R collaboration, Protagonist was primarily responsible for development of icotrokinra through Phase 1, with JNJ assuming responsibility for development in Phase 2 and beyond. Rusfertide, a mimetic of the natural hormone hepcidin, is currently in Phase 3 development for the rare blood disorder polycythemia vera (PV). Rusfertide is being co-developed and will be co-commercialized with Takeda Pharmaceuticals pursuant to a worldwide collaboration and license agreement entered in 2024 under which the Company remains primarily responsible for development through NDA filing. The Company also has a number of pre-clinical stage drug discovery programs addressing clinically and commercially validated targets, including IL-17 oral peptide antagonist PN-881, an obesity triple agonist peptide PN-477, and the oral hepcidin program.

More information on Protagonist, its pipeline drug candidates and clinical studies can be found on the Company’s website at https://www.protagonist-inc.com/.

Cautionary Note on Forward-Looking Statements
This press release contains forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding the potential benefits of rusfertide and the timing of rusfertide regulatory submissions. In some cases, you can identify these statements by forward-looking words such as “anticipate,” “believe,” “may,” “will,” “expect,” or the negative or plural of these words or similar expressions. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated, including, but not limited to, our ability to develop and commercialize our product candidates, our ability to earn milestone payments under our collaboration agreements with Janssen and Takeda, our ability to use and expand our programs to build a pipeline of product candidates, our ability to obtain and maintain regulatory approval of our product candidates, our ability to operate in a competitive industry and compete successfully against competitors that have greater resources than we do, and our ability to obtain and adequately protect intellectual property rights for our product candidates. Additional information concerning these and other risk factors affecting our business can be found in our periodic filings with the Securities and Exchange Commission, including under the heading “Risk Factors” contained in our most recently filed periodic reports on Form 10-K and Form 10-Q filed with the Securities and Exchange Commission. Forward-looking statements are not guarantees of future performance, and our actual results of operations, financial condition and liquidity, and the development of the industry in which we operate, may differ materially from the forward-looking statements contained in this press release. Any forward-looking statements that we make in this press release speak only as of the date of this press release. We assume no obligation to update our forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this press release.

Investor Relations Contact
Corey Davis, Ph.D.
LifeSci Advisors
cdavis@lifesciadvisors.com
+1 212 915 2577

Media Relations Contact
Virginia Amann
ENTENTE Network of Companies
virginiaamann@ententeinc.com
+1 833 500 0061 ext 1

Endnotes

View the original press release on ACCESS Newswire

LONDON, UK AND VANCOUVER, BC / ACCESS Newswire / August 25, 2025 / CoTec Holdings Corp. (TSXV:CTH)(OTCQB:CTHCF) (“CoTec”) and Mkango Resources Ltd. (AIM/TSX-V: MKA) (“Mkango”) are pleased to announce that Intelligent Lifecycle Solutions LLC (“ILS”) has formally commenced its stockpiling of feedstock initiative pursuant to the recently announced feedstock supply and pre-processing site share agreement between HyProMag USA LLC (“HyProMag USA” or the “Project”) and ILS. Pre-processing of the feedstock is expected to commence prior to December 31, 2025.

The stockpiling and pre-processing will take place at both the ILS sites in Williston, South Carolina and Reno, Nevada (the “ILS sites”). ILS is a global electronics recycling company processing electronic waste. It is a full-service IT asset disposition, electronics recycling and scrap purchasing company and is fully compliant in ISO 14001:2015, ISO 45001:2018 and “Responsible Recycling R2v3 Recycler” at its USA locations. Through ILS, HyProMag USA will provide full traceability on its products to support the “closed loop” circular economy and critical mineral supply chains within the United States.

Julian Treger, CoTec CEO commented:“This is another major milestone in the execution of the HyProMag USA project. Securing feedstock is key to the success of any recycling business and we are pleased to work with credible companies such as ILS. HyProMag USA’s target is to secure between 6 months and 12 months of feedstock prior to commissioning of HyProMag USA’s advanced stage rare earth magnet recycling and manufacturing plant to be located in Dallas-Fort Worth, Texas. HyProMag USA aims to become a major contributor to the USA supply chain of rare earth magnets, a critical input for accelerating the reshoring of the U.S industrial base.”

Will Dawes, Mkango CEO commented: “The agreement with ILS and commencement of stockpiling of NdFeB feedstock underpins the rapid deployment of Hydrogen Processing of Magnet Scrap (HPMS) and associated magnet manufacturing into the United States by HyProMag USA, with detailed engineering well underway following the positive feasibility study last year. These developments will catalyse development of a more robust rare earth supply chain, whilst unlocking new NdFeB scrap sources in the United States and generating significant value for HyProMag USA and its stakeholders.”

About HyProMag USA LLC.

HyProMag USA is owned 50:50 by CoTec and HyProMag Limited. HyProMag Limited is 100 per cent owned by Maginito (“Maginito”), which is owned on a 79.4/20.6 per cent basis by Mkango and CoTec.

For more information, please visit www.hypromagusa.com

About CoTec Holdings Corp.

CoTec is a publicly traded investment issuer listed on the Toronto Venture Stock Exchange (“TSX- V”) and the OTCQB and trades under the symbols CTH and CTHCF respectively. CoTec Holdings Corp. is a forward-thinking resource extraction company committed to revolutionizing the global metals and minerals industry through innovative, environmentally sustainable technologies and strategic asset acquisitions. With a mission to drive the sector toward a low-carbon future, CoTec employs a dual approach: investing in disruptive mineral extraction technologies that enhance efficiency and sustainability while applying these technologies to undervalued mining assets to unlock their full potential. By focusing on recycling, waste mining, and scalable solutions, the Company accelerates the production of critical minerals, shortens development timelines, and reduces environmental impact. CoTec’s strategic model delivers low capital requirements, rapid revenue generation, and high barriers to entry, positioning it as a leading mid-tier disruptor in the commodities sector.

For more information, please visit www.cotec.ca.

About Mkango Resources Ltd.

Mkango is listed on the AIM and the TSX-V. Mkango’s corporate strategy is to become a market leader in the production of recycled rare earth magnets, alloys and oxides, through its interest in Maginito Limited (“Maginito”), which is owned 79.4 per cent by Mkango and 20.6 per cent by CoTec, and to develop new sustainable sources of neodymium, praseodymium, dysprosium and terbium to supply accelerating demand from electric vehicles, wind turbines and other clean energy technologies.

Maginito holds a 100 per cent interest in HyProMag and a 90 per cent direct and indirect interest (assuming conversion of Maginito’s convertible loan) in HyProMag GmbH, focused on short loop rare earth magnet recycling in the UK and Germany, respectively, and a 100 per cent interest in Mkango Rare Earths UK Ltd (“Mkango UK”), focused on long loop rare earth magnet recycling in the UK via a chemical route.

Maginito and CoTec are also rolling out HPMS recycling technology into the United States via the 50/50 owned HyProMag USA LLC joint venture company.

Mkango also owns the advanced stage Songwe Hill rare earths project in Malawi (“Songwe”) and the Pulawy rare earths separation project in Poland (“Pulawy”). Both the Songwe and Pulawy projects have been selected as Strategic Projects under the European Union Critical Raw Materials Act. Mkango has signed a Binding Combination Agreement with Crown PropTech Acquisitions to list the Songwe Hill and Pulawy rare earths projects on NASDAQ via a SPAC Merger.

For more information, please visit www.mkango.ca

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 (‘MAR’) which has been incorporated into UK law by the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

Cautionary Note Regarding Forward-Looking Statements

This news release contains forward-looking statements (within the meaning of that term under applicable securities laws) with respect to Mkango and CoTec. Generally, forward looking statements can be identified by the use of words such as “plans”, “expects” or “is expected to”, “scheduled”, “estimates” “intends”, “anticipates”, “believes”, or variations of such words and phrases, or statements that certain actions, events or results “can”, “may”, “could”, “would”, “should”, “might” or “will”, occur or be achieved, or the negative connotations thereof. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. Such factors and risks include, without limiting the foregoing, the delivery and effectiveness of the HDD magnet separation system built by Inserma, the results of the Accelerated Pilot Programme at UoB, the availability of (or delays in obtaining) financing to develop Songwe Hill, the Recycling Plants being developed by Maginito in the UK, Germany and the US (the “Maginito Recycling Plants”), governmental action and other market effects on global demand and pricing for the metals and associated downstream products for which Mkango is exploring, researching and developing, geological, technical and regulatory matters relating to the development of Songwe Hill, the ability to scale the HPMS and chemical recycling technologies to commercial scale, competitors having greater financial capability and effective competing technologies in the recycling and separation business of Maginito and Mkango, availability of scrap supplies for Maginito’s recycling activities, government regulation (including the impact of environmental and other regulations) on and the economics in relation to recycling and the development of the Maginito Recycling Plants, and Pulawy and future investments in the United States pursuant to the proposed cooperation agreement between Maginito and CoTec, cost overruns, complexities in building and operating the plants, and the positive results of feasibility studies on the various proposed aspects of Mkango’s, Maginito’s and CoTec’s activities. The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company and CoTec disclaim any intention and assume no obligation to update or revise any forward-looking statements, whether because of new information, future events or otherwise, except as required by applicable law. Additionally, the Company and CoTec undertake no obligation to comment on the expectations of, or statements made by, third parties in respect of the matters discussed above.

For further information on CoTec, please contact:

CoTec Holdings Corp.
Braam Jonker
Chief Financial Officer
braam.jonker@cotec.ca
Canada: +1 604 992-5600

For further information on Mkango, please contact:

SP Angel Corporate Finance LLP
Nominated Adviser and Joint Broker
Jeff Keating, Jen Clarke, Devik Mehta
UK: +44 20 3470 0470

Alternative Resource Capital
Joint Broker
Alex Wood, Keith Dowsing
UK: +44 20 7186 9004/5

The TSX Venture Exchange has neither approved nor disapproved the contents of this press release. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any equity or other securities of the Company in the United States. The securities of the Company will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) and may not be offered or sold within the United States to, or for the account or benefit of, U.S. persons except in certain transactions exempt from the registration requirements of the U.S. Securities Act.

SOURCE: CoTec Holdings Corp.

View the original press release on ACCESS Newswire